MONROVIA, CA, November 22, 2008
/24-7PressRelease/ -- Dr. Michael Karin, Professor of Pharmacology Tumor Growth Invasion & Metastasis at the University of California, San Diego will give the keynote address entitled "IL-6 and STAT3 are required for Survival of Intestinal Epithelial Cells and Development of Colitis Associated Cancer" at the 7th annual Cytokines & Inflammation Conference on January 29-30, 2009 in San Diego, CA.
Dr. Karin will discuss how Interleukin-6 (IL-6) may regulate pre-neoplastic growing during colitis associated cancer (CAC), the most severe complication of ulcerative colitis. Dr. Karin and his group, using genetic tools, have demonstrated that IL-6 is crucial during early CAC tumorgenesis as a tumor promoter. During his presentation on January 30th, he will provide more in-depth details of his research and findings.
Other notable presenters at the conference include Dr. Jay Rothstein, Director of Inflammation Research at Amgen and Barbara White, Vice President, Clinical Development, Inflammatory Disease at MedImmune.
The goal of the 7th Annual Cytokines and Inflammation Conference is to provide an overview of the state of the art developments in cytokine signaling & regulation, inflammation, cancer, pathogenesis of diseases, chemokines, technological developments, cytokine receptors, bringing together a mix of academic, industry (Pharma and Biotech) and public sector experts in an intimate setting that favors the showcase of data, the exchange of ideas and networking. For more information visit http://gtcbio.com/conferenceDetails.aspx?id=141.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com
# # #
Read more Press Releases from Rania Hafez:- De Yang from the National Cancer Institute to Speak at the 7th Cytokines & Inflammation Conference
- Gregory A. Bonfiglio, Managing Partner at Proteus Venture Partners to Give Featured Presentation at 5th Stem Cell Research & Therapeutics Conference
- Charles Peterfy, Chief Scientific Officer at Synarc to Give Featured Presentation at GTCbio's 4th Imaging in Preclinical & Clinical Drug Development Conference
- GTCbio Announces its 7th Annual Cytokines & Inflammation Conference
- Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center to Give Keynote Speech at GTCbio's 2nd Oncology Biomarkers Conference on January 19-20 in Miami, Florida
- GTCbio Announces its 2nd Annual Oncology Biomarkers Conference
- Michael Shih, Director of Business Development at Eisai Inc. and Deepa Talpade, Director of Global Licensing & Strategic Alliances at Schering Plough to Give Joint Featured Presentation at GTCbio's CNS Diseases Partnering & Deal-Making Summit on Dec. 1-2, 2008 in Boston, MA
- GTCBIO ANNOUNCES ITS INAUGURAL CNS DISEASES PARTNERING & DEAL-MAKING SUMMIT
- Johan Luthman, Global Head of Exploratory Medicine Neurology at MerckSerono to Give Plenary Keynote Address at 4th Modern Drug Discovery & Development Summit (Oct. 15-17, 2008 - San Diego, CA)
- Herbert Fritsche, Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center to Give Keynote Presentation at GTCbio's Biomarker Discovery Europe Conference on October 2-3, 2008 in Dublin, Ireland
Other Press Release Headlines:
